This indicated that vaccination with N2A-IL-2+IL-12 cells generated a superior overall antitumour effect with 91% of treated animals displaying tumour eradication or retarded growth, compared with cells expressing IL-12 alone, where only 63% of treated animals showed one of these responses (Figure 5B). Here, IL2 is linked to neoplasm.